These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 632338)

  • 1. Simple and rapid micro-determination of sulfinpyrazone (Anturan) in biological fluids by reversed-phase high-performance liquid chromatography.
    Wong LT; Solomonraj G; Thomas BH
    J Chromatogr; 1978 Mar; 150(2):521-6. PubMed ID: 632338
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of sulfinpyrazone and its metabolites in human plasma and urine by high-performance liquid chromatography.
    de Vries JX; Staiger C; Wang NS; Schlicht F
    J Chromatogr; 1983 Oct; 277():408-13. PubMed ID: 6643630
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of sulfinpyrazone and four metabolites in plasma and urine by high pressure liquid chromatography.
    Lentjes EG; Tan Y; Van Ginneken CA
    Pharm Weekbl Sci; 1985 Dec; 7(6):252-9. PubMed ID: 4080510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assay of sulphinpyrazone in plasma and urine by high-performance liquid chromatography.
    Lecaillon JB; Souppart C
    J Chromatogr; 1976 Jun; 121(2):227-34. PubMed ID: 932142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic analysis of sulfinpyrazone and its metabolites in biological fluids.
    Bjornsson TD; Wolfram KM; Routledge PA; Shand DG
    J Chromatogr; 1980 Mar; 181(3-4):417-25. PubMed ID: 7391155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic determination of sulfinpyrazone and its metabolites in plasma.
    Kuo BS; Kaplan LA; Ritschel WA
    Arzneimittelforschung; 1984; 34(5):548-50. PubMed ID: 6540568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of sulfinpyrazone and four of its metabolites by high-performance liquid chromatography.
    Jakobsen P; Pedersen AK
    J Chromatogr; 1981 May; 223(2):460-5. PubMed ID: 7251803
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of azobenzene and hydrazobenzene in phenylbutazone and sulfinpyrazone products by high-performance liquid chromatography.
    Matsui F; Lovering EG; Curran NM; Watson JR
    J Pharm Sci; 1983 Oct; 72(10):1223-4. PubMed ID: 6644580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paired-ion high-performance liquid chromatographic assay for sulfinpyrazone in plasma.
    Patel NJ; Kildsig DO; Banker GS; Mayer PR; Gonzalez MA
    J Pharm Sci; 1982 Dec; 71(12):1413-5. PubMed ID: 7153896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple and rapid high-performance liquid chromatographic method for the analysis of sulfinpyrazone and four of its metabolites in human plasma.
    Tam YK; Ferguson SM; Yau ML; Wyse DG
    J Chromatogr; 1984 Oct; 310(2):438-44. PubMed ID: 6511862
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of sulfinpyrazone and two of its metabolites in human plasma and urine by gas chromatography and selective detection.
    Jakobsen P; Pedersen AK
    J Chromatogr; 1979 Jul; 163(3):259-69. PubMed ID: 541381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic analysis of the sulfide metabolite of sulfinpyrazone in plasma.
    Godbillon J; Gauron S; Gosset G
    J Chromatogr; 1982 Feb; 227(2):516-20. PubMed ID: 7061662
    [No Abstract]   [Full Text] [Related]  

  • 13. Excretion of sulfinpyrazone in the rat.
    Aldridge A; Johnson GE
    Can J Physiol Pharmacol; 1972 Nov; 50(11):1061-5. PubMed ID: 4640798
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of sulfinpyrazone in serum by high-performance liquid chromatography.
    Inaba T; Besley ME; Chow EJ
    J Chromatogr; 1975 Jan; 104(1):165-9. PubMed ID: 166080
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on kinetics of anturan excretion in man.
    Seńczuk W; Jodynis-Liebert J
    Int J Clin Pharmacol Biopharm; 1979 Jul; 17(7):303-6. PubMed ID: 489196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative drug elimination capacity in man-glutethimide, amobarbital, antipyrine, and sulfinpyrazone.
    Kadar D; Inaba T; Endrenyi L; Johnson GE; Kalow W
    Clin Pharmacol Ther; 1973; 14(4):552-60. PubMed ID: 4723263
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics and metabolism of sulfinpyrazone.
    Mahony C; Wolfram KM; Nash PV; Bjornsson TD
    Clin Pharmacol Ther; 1983 Apr; 33(4):491-7. PubMed ID: 6831828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The site of reduction of sulphinpyrazone in the rabbit.
    Strong HA; Renwick AG; George CF
    Xenobiotica; 1984 Oct; 14(10):815-26. PubMed ID: 6506754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of sulfinpyrazone on the arteriosclerotic changes in various animal models].
    Clopath P; Horsch AK; Dieterle W
    Wien Med Wochenschr Suppl; 1980; 61():9-16. PubMed ID: 7395250
    [No Abstract]   [Full Text] [Related]  

  • 20. New metabolites of sulfinpyrazone in man.
    Dieterle W; Faigle JW; Moppert J
    Arzneimittelforschung; 1980; 30(6):989-93. PubMed ID: 7191279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.